This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Podcast
Aspirin to Prevent Colorectal Cancer - Frankly Speaking EP 218Guest: Robert A. Baldor, MD, FAAFP
Music Credit: Richard Onorato
Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice.
Episode References and Resources:
- www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
- doi:10.1001/jamaoncol.2020.7338
- N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955
Begin
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 4/5/2021
Expiration Date: 4/5/2022
Topics
Learning Objectives
- Summarize the United States Preventive Services Task Force (USPSTF) recommendations related to the use of aspirin (ASA) in colorectal cancer prevention
- Review the data behind the USPSTF recommendations
- Identify patients for whom it may be appropriate to offer ASA as a colorectal cancer prevention strategy
Faculty
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Robert A. Baldor, MD, FAAFP
Professor and Chairman, Dept of Family Medicine
UMass Medical School/Baystate
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable